BUFFALO, N.Y. and CHICAGO, June 13,
2020 /PRNewswire/ -- Athenex, Inc. (NASDAQ: ATNX), a
global biopharmaceutical company dedicated to the discovery,
development, and commercialization of novel therapies for the
treatment of cancer, today announced that Athenex Oncology, a U.S.
based division of Athenex, launched Facing MBC Together – a
public education and patient support campaign that addresses
isolation for people living with metastatic breast cancer (MBC). In
addition to providing a unique digital resource that enables the
provision of practical and emotional support to individuals with
MBC, the campaign, which Athenex Oncology unveiled at the Living
Beyond Breast Cancer (LBBC) 2020 Virtual Conference on Metastatic
Breast Cancer, highlights the stories of nine people of diverse
ages and backgrounds who share their insights about the challenges
they face, sources of support, and words of encouragement for
others living with this advanced form of breast cancer.
Experience the interactive Multichannel News Release here:
https://www.multivu.com/players/English/8724751-athenex-oncology-facing-mbc-together/
Athenex Oncology is launching Facing MBC Together in
recognition of the prevalence and impact of isolation on the lives
of individuals with MBC. In a recent survey of 273 MBC patients and
survivors from Cancer Support Community's Cancer Experience
Registry® (CER), nearly one-third of participants reported moderate
to very serious concern about feeling lonely or
isolated.1 Such findings suggest that isolation is a
growing yet underappreciated phenomenon in the MBC community.
"The Facing MBC Together campaign reflects our
desire to support the metastatic breast cancer community in
meaningful ways," said Timothy Cook,
senior vice president, global oncology at Athenex. "Its launch is
especially timely, as the COVID-19 pandemic has exacerbated
patients' feelings of loneliness and isolation. By sharing the
stories of a diverse group of people with MBC – eight women and one
man – we aim to motivate patients to seek help to alleviate
their isolation, and to remind them that they are not alone."
The centerpiece of the Facing MBC Together campaign is a
digital resource designed to enable those living with MBC to create
a private support group to positively impact their well-being
and/or lessen some of the burden of their day-to-day tasks. The
resource features numerous tools, including a customizable calendar
that allows supporters to fulfill a loved one's everyday requests
such as driving them to treatment, walking a pet, delivering meals,
or picking up groceries; a real-time video channel that lets people
connect live, one-to-one, or in a group chat; a health update blog
that may be used to share medical updates or other information
about the people and family living with MBC; and a photo and video
gallery, by which supporters can upload visual images to lift their
loved one's spirits, offer encouragement, and rally support.
"I'm proud to be part of Facing MBC Together, and also
glad to have access to the campaign's resources, especially
during this difficult time," said Stephanie, a nurse who is one of
the patients profiled in Facing MBC Together. "The COVID-19
pandemic is impacting our access to cancer treatments, clinical
trials, and medical attention, and for many of us our mental health
needs are being ignored. Living with MBC has helped me to deal with
panic, uncertainty, and isolation. Facing MBC Together, with
its tangible resources, is invaluable for staying organized and
getting extra support where needed."
For more information about Facing MBC Together, visit
FacingMBCtogether.com
About Athenex Oncology
Athenex Oncology is a U.S.-based division of Athenex, Inc.
(Athenex) (NASDAQ: ATNX). Athenex's pipeline includes
small-molecule, biologic, and cellular-based anticancer therapies,
and comprises a range of therapeutic approaches designed to improve
patient care by addressing specific therapeutic
limitations. The Athenex Oncology brand was established in
2019 to provide accessible information and multiple resources to
oncology customers, including healthcare professionals, patients,
and caregivers, who may benefit from Athenex's broad pipeline of
innovative oncology products. By rethinking the challenges
associated with certain anticancer treatments, Athenex Oncology can
help expand the range of available treatment options for
patients.
For more information about Athenex
Oncology, please
visit www.AthenexOncology.com
About Athenex, Inc.
Founded in 2003, Athenex, Inc. is a global clinical
stage biopharmaceutical company dedicated to becoming a leader in
the discovery, development and commercialization of next generation
drugs for the treatment of cancer. Athenex is organized
around three platforms, including an Oncology Innovation Platform,
a Commercial Platform and a Global Supply Chain Platform. Athenex's
employees worldwide are dedicated to improving the lives of cancer
patients by creating more active and tolerable
treatments. Athenex has offices
in Buffalo and Clarence, New York; Cranford,
New Jersey; Houston, Texas; Chicago, Illinois; Hong
Kong; Taipei, Taiwan; multiple locations
in Chongqing, China; Manchester, UK; Guatemala
City, Guatemala and Buenos
Aires, Argentina.
For more information, please visit www.athenex.com
Reference
1 Zaleta AK, Miller MF, McManus S, Clark KA, Jaisle
A, Saxton MC. Predictors of social function and feelings of
isolation among metastatic breast cancer survivors. In:
Proceedings of the San Antonio Breast Cancer Symposium. 2019
Dec. 10-14; San Antonio, TX. Cancer Research 2020;80(4
Suppl):Abstract nr P2-13-12.
View original
content:http://www.prnewswire.com/news-releases/athenex-oncology-launches-facing-mbc-together-campaign-to-address-isolation-for-people-living-with-metastatic-breast-cancer-301075377.html
SOURCE Athenex Oncology